What is included in the monitoring of mold-related allergic bronchopulmonary aspergillosis (ABPA) and allergic bronchopulmonary mycosis (ABPM)?

Updated: Sep 18, 2017
  • Author: Shih-Wen Huang, MD; Chief Editor: Harumi Jyonouchi, MD  more...
  • Print
Answer

Diagnosis can be established on an outpatient basis by finding eosinophilia, elevated total serum IgE value, and a skin test positive for the suspected fungi; by finding precipitin antibody against suspected fungi; or by finding hyphae or positive sputum culture results for fungi.

Drug therapy begins with an oral corticosteroid followed by a corticosteroid inhaler if the condition improves. Patients should be monitored every 3 months with spirometer measurement of airflow.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!